Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Status:
Suspended
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This randomized pilot clinical trial studies how well propranolol hydrochloride works in
treating patients with prostate cancer who are undergoing surgery. When stressed, the body
makes a molecule that may prevent tumor cells from dying, and propranolol hydrochloride may
affect the signals in cells that cause tumor cells survival and death.